Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder

被引：7
|
作者：
Fontenelle, LF
Mendlowicz, MV
Miguel, EC
Versiani, M
机构：
[1] IPUB UFRJ, Inst Psychiat, Anxiety & Depress Res Program, Rio De Janeiro, Brazil
[2] IPUB UFRJ, Inst Psychiat, Ethics & Forens Psychiat Res Program, Rio De Janeiro, Brazil
[3] UFF, MSM, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil
[4] USP, Sch Med, Obsess Compuls Spectrum Disorders Clin PROTOG, Dept Psychiat, BR-09500900 Sao Paulo, Brazil
来源：
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY | 2005年 / 6卷 / 01期
关键词：
obsessive-compulsive disorder; citalopram; reboxetine;
D O I：
10.1080/15622970510029740
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
While serotonin reuptake inhibitors (SRIs) are the first-line treatment of obsessive-compulsive disorder (OCD), as many as 40-60% of patients fail to respond to adequate trials with these drugs. In this study, we describe the case of a patient with an SRI-resistant OCD who was successfully treated with a combination of citalopram (a selective SRI) and reboxetine (a selective noradrenaline reuptake inhibitor (SNRI)). This report suggests that future studies accessing the efficacy of the SRI-SNRI combination in treatment resistant OCD are needed.
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [1] Citalopram for treatment-resistant obsessive-compulsive disorder
    Pallanti, S
    Quercioli, L
    Paiva, RS
    Koran, LM
    EUROPEAN PSYCHIATRY, 1999, 14 (02) : 101 - 106
  • [2] Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder
    Bejerot, S
    Bodlund, O
    ACTA PSYCHIATRICA SCANDINAVICA, 1998, 98 (05) : 423 - 424
  • [3] Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Dell'Osso, B
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) : 189 - 191
  • [4] How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs, Georgina
    Isomura, Kayoko
    Lang, Katie
    Jassi, Amita
    Heyman, Isobel
    Diamond, Holly
    Advani, Jana
    Turner, Cynthia
    Mataix-Cols, David
    BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 2015, 54 (01) : 63 - 75
  • [5] Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
    Karameh, Wael Karameh
    Khani, Munir
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (02)
  • [6] Toxoplasmosis in Treatment-Resistant Obsessive-Compulsive Disorder Patients
    Kazemi, Forough
    Sayyah, Mehdi
    Tavalla, Mehdi
    Arjmand, Reza
    ACTA PARASITOLOGICA, 2022, 67 (01) : 356 - 361
  • [7] Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder
    Gershuny, Beth S.
    Baer, Lee
    Parker, Holly
    Gentes, Emily L.
    Infield, Alison L.
    Jenike, Michael A.
    DEPRESSION AND ANXIETY, 2008, 25 (01) : 69 - 71
  • [8] Bilateral Anterior Capsulotomy for Treatment-Resistant Obsessive-Compulsive Disorder
    Hurwitz, Trevor
    Ching, Geoffrey
    Bogod, Nicholas Mark
    Honey, Christopher R.
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2024, 102 (06) : 356 - 370
  • [9] Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder
    Walsh, KH
    McDougle, CJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2059 - 2067
  • [10] Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study
    Koponen, H
    Lepola, U
    Leinonen, E
    Jokinen, R
    Penttinen, J
    Turtonen, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 (05) : 343 - 346
12345